Am J Psychiatry 156:1944-1950, December 1999
© 1999 American Psychiatric Association
Repeatable Battery for the Assessment of Neuropsychological Status as a Screening Test in Schizophrenia, I: Sensitivity, Reliability, and Validity
James M. Gold, Ph.D.,
Caleb Queern, B.A.,
Virginia N. Iannone, M.A., and
Robert W. Buchanan, M.D.
OBJECTIVE: Cognitive impairment is an important feature of schizophrenia and is correlated with functional outcome. However, psychiatry lacks a screening instrument that can reliably assess the types of cognitive impairment often seen in schizophrenia. The authors assessed the sensitivity, convergent validity, and reliability of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) as well as the relationship of the RBANS to symptoms and employment status. This newly published test takes 25 minutes to administer and was standardized on a U.S.-Census-matched adult population. The test provides a total score and five index scores, each with a mean value of 100 (SD=15). METHOD: RBANS data were obtained from 129 patients with schizophrenia in the outpatient and inpatient programs of the Maryland Psychiatric Research Center. RBANS data were correlated with WAIS-III and Wechsler Memory Scale, 3rd ed. performance in 38 patients. Reliability data for alternate forms of the RBANS were obtained from 53 patients; symptom ratings were obtained from 48 patients; and employment status was examined in 77 patients. RESULTS: The patients with schizophrenia demonstrated marked impairment on the RBANS (their mean total score was 71.4). The patients’ index scores suggested that they had relatively less impairment of language and visual functions than of memory and attention. The RBANS demonstrated high correlations with full-scale IQ and memory measures. The total score demonstrated good reliability. RBANS performance minimally correlated with Brief Psychiatric Rating Scale ratings but was strongly related to employment outcome. CONCLUSIONS: The RBANS appears to be a useful cognitive screening instrument in schizophrenia. The instrument may be a useful prognostic indicator and offers a means of assessing cognitive status.
This article has been cited by other articles:
|
|
|
|
 
D. Dickinson, J. M. Gold, F. B. Dickerson, D. Medoff, and L. B. Dixon
Evidence of Exacerbated Cognitive Deficits in Schizophrenia Patients With Comorbid Diabetes
Psychosomatics,
April 1, 2008;
49(2):
123 - 131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.S. Turk, I. Chaudry, V.M. Haughton, B.P. Hermann, H.A. Rowley, K. Pulfer, B. Aagaard-Kienitz, D.B. Niemann, P.A. Turski, R.L. Levine, et al.
Effect of Carotid Artery Stenting on Cognitive Function in Patients With Carotid Artery Stenosis: Preliminary Results
AJNR Am. J. Neuroradiol.,
February 1, 2008;
29(2):
265 - 268.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Altshuler, J. Tekell, K. Biswas, A. M. Kilbourne, D. Evans, D. Tang, and M. S. Bauer
Executive Function and Employment Status Among Veterans With Bipolar Disorder
Psychiatr Serv,
November 1, 2007;
58(11):
1441 - 1447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Buchanan, R. Freedman, D. C. Javitt, A. Abi-Dargham, and J. A. Lieberman
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
Schizophr Bull,
September 1, 2007;
33(5):
1120 - 1130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Kraus and R. S. E. Keefe
Cognition as an outcome measure in schizophrenia
The British Journal of Psychiatry,
August 1, 2007;
191(50):
s46 - s51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. E. Keefe, R. M. Bilder, S. M. Davis, P. D. Harvey, B. W. Palmer, J. M. Gold, H. Y. Meltzer, M. F. Green, G. Capuano, T. S. Stroup, et al.
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
Arch Gen Psychiatry,
June 1, 2007;
64(6):
633 - 647.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bromley
Barriers to the Appropriate Clinical Use of Medications That Improve the Cognitive Deficits of Schizophrenia
Psychiatr Serv,
April 1, 2007;
58(4):
475 - 481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Duff, D. R. Langbehn, M. R. Schoenberg, D. J. Moser, L. E. Baade, J. Mold, J. G. Scott, and R. L. Adams
Examining the Repeatable Battery for the Assessment of Neuropsychological Status: Factor Analytic Studies in an Elderly Sample.
Am J Geriatr Psychiatry,
November 1, 2006;
14(11):
976 - 979.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Olincy, J. G. Harris, L. L. Johnson, V. Pender, S. Kongs, D. Allensworth, J. Ellis, G. O. Zerbe, S. Leonard, K. E. Stevens, et al.
Proof-of-Concept Trial of an {alpha}7 Nicotinic Agonist in Schizophrenia.
Arch Gen Psychiatry,
June 1, 2006;
63(6):
630 - 638.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. B. Dickerson, J. J. Boronow, C. R. Stallings, A. E. Origoni, S. Cole, and R. H. Yolken
Association Between Cognitive Functioning and Employment Status of Persons With Bipolar Disorder
Psychiatr Serv,
January 1, 2004;
55(1):
54 - 58.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. B. Dickerson, J. J. Boronow, C. Stallings, A. E. Origoni, I. Ruslanova, and R. H. Yolken
Association of Serum Antibodies to Herpes Simplex Virus 1 With Cognitive Deficits in Individuals With Schizophrenia
Arch Gen Psychiatry,
May 1, 2003;
60(5):
466 - 472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Copersino, M. Serper, and M. H. Allen
Emergency Psychiatry: Rapid Screening for Cognitive Impairment in the Psychiatric Emergency Service: II. A Flexible Test Strategy
Psychiatr Serv,
March 1, 2003;
54(3):
314 - 316.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Weber
RBANS has reasonable test-retest reliability in schizophrenia
Evid. Based Ment. Health,
February 1, 2003;
6(1):
22 - 22.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
